Johnson & Johnson Innovative Medicine Switzerland hat dies direkt geteilt
Leila Schwery (Bou-Diab), VP Manufacturing & Technical Operations, Johnson & Johnson Innovative Medicine, shared her insights in the NZZ on how Switzerland can maintain its leadership in innovation. Her three key wishes include strengthening collaborations between science and industry, supporting start-ups with innovation-friendly regulations and better access to venture capital, and fully integrating digitalization and AI into Switzerland’s innovation strategy. Read more about how Switzerland can stay at the forefront of life-saving innovation: https://lnkd.in/dviy22_k #Innovation #JNJswitzerland